Enteropathogenic Escherichia coli (EPEC) effector-mediated suppression of antimicrobial nitric oxide production in a small intestinal epithelial model system

Cellular Microbiology

Volumn 7, Issue 12, 2005, Pages 1749-1762

  Maresca, Marc ^a,b   Miller, Deborah ^a,c   Quitard, Sabine ^a   Dean, Paul ^a   Kenny, Brendan ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIV MONTPELLIER   (France)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; NITRIC OXIDE; STAT1 PROTEIN; TRANSCRIPTION FACTOR;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; CONTROLLED STUDY; ENTEROBACTER INFECTION; ENZYME INHIBITION; ENZYME SYNTHESIS; ESCHERICHIA COLI; GENETIC TRANSCRIPTION; HOST CELL; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM; INTESTINE INFECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

BACTERIAL ADHESION; CACO-2 CELLS; CYTOKINES; DOWN-REGULATION; ENZYME INHIBITORS; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; HUMANS; INTESTINAL MUCOSA; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHORYLATION;

BACTERIA (MICROORGANISMS); ENTEROBACTER; ESCHERICHIA COLI;

EID: 28044443654     PISSN: 14625814     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1462-5822.2005.00587.x     Document Type: Article

References (73)

1. Alam, M.S., Akaike, T., Okamoto, S., Kubota, T., Yoshitake, J., Sawa, T., et al. (2002) Role of nitric oxide in host defense in murine salmonellosis as a function of its antibacterial and antiapoptotic activities. Infect Immun 70: 3130-3142.
2. Beckman, J.S., Beckman, T.W., Chen, J., Marshall, P.A., and Freeman, B.A. (1990) Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87: 1620-1624.
3. Berkes, J., Viswanathan, V.K., Savkovic, S.D., and Hecht, G. (2003) Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation. Gut 52: 439-451.
4. Cavicchi, M., and Whittle, B.J. (1999) Regulation of induction of nitric oxide synthase and the inhibitory actions of dexamethasone in the human intestinal epithelial cell line, Caco-2: influence of cell differentiation. Br J Pharmacol 128: 705-715.
5. Ceponis, P.J., McKay, D.M., Ching, J.C., Pereira, P., and Sherman, P.M. (2003) Enterohemorrhagic Escherichia coli O157:H7 disrupts Stat1-mediated gamma interferon signal transduction in epithelial cells. Infect Immun 71: 1396-1404.
6. Chen, L.F., and Greene, W.C. (2004) Shaping the nuclear action of NF-kappaB. Nat Rev Mol Cell Biol 5: 392-401.
7. Clarke, S.C., Haigh, R.D., Freestone, P.P., and Williams, P.H. (2003) Virulence of enteropathogenic Escherichia coli, a global pathogen. Clin Microbiol Rev 16: 365-378.
8. Dean, P., and Kenny, B. (2004) Intestinal barrier dysfunction by enteropathogenic Escherichia coli is mediated by two effector molecules and a bacterial surface protein. Mol Microbiol 54: 665-675.
9. Dean, P., Maresca, M., and Kenny, B. (2005) EPEC's weapons of mass subversion. Curr Opin Microbiol 8: 28-34.
10. Delie, F., and Rubas, W. (1997) A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: advantages and limitations of the Caco-2 model. Crit Rev Ther Drug Carrier Syst 14: 221-286.
11. Deng, W., Vallance, B.A., Li, Y., Puente, J.L., and Finlay, B.B. (2003) Citrobacter rodentium translocated intimin receptor (Tir) is an essential virulence factor needed for actin condensation, intestinal colonization and colonic hyperplasia in mice. Mol Microbiol 48: 95-115.
12. Deng, W., Puente, J.L., Gruenheid, S., Li, Y., Vallance, B.A., Vazquez, A., et al. (2004) Dissecting virulence: systematic and functional analyses of a pathogenicity island. Proc Natl Acad Sci USA 101: 3597-3602.
13. Dharmsathaphorn, K., and Pandol, S.J. (1986) Mechanism of chloride secretion induced by carbachol in a colonic epithelial cell line. J Clin Invest 77: 348-354.
14. Dijkstra, G., van Goor, H., Jansen, P.L., and Moshage, H. (2004) Targeting nitric oxide in the gastrointestinal tract. Curr Opin Invest Drugs 5: 529-536.
15. Donnenberg, M.S., and Kaper, J.B. (1991) Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive-selection suicide vector. Infect Immun 59: 4310-4317.
16. Donnenberg, M.S., Calderwood, S.B., Donohue-Rolfe, A., Keusch, G.T., and Kaper, J.B. (1990) Construction and analysis of TnphoA mutants of enteropathogenic Escherichia coli unable to invade HEp-2 cells. Infect Immun 58: 1565-1571.
17. Donnenberg, M.S., Yu, J., and Kaper, J.B. (1993) A second chromosomal gene necessary for intimate attachment of enteropathogenic Escherichia coli to epithelial cells. J Bacteriol 175: 4670-4680.
18. Eckmann, L., Jung, H.C., Schurer-Maly, C., Panja, A., Morzycka-Wroblewska, E., and Kagnoff, M.F. (1993) Differential cytokine expression by human intestinal epithelial cell lines: regulated expression of interleukin 8. Gastroenterology 105: 1689-1697.
19. Elliott, S.N., and Wallace, J.L. (1998) Nitric oxide: a regulator of mucosal defense and injury. J Gastroenterol 33: 792-803.
20. Elliott, S.J., Krejany, E.O., Mellies, J.L., Robins-Browne, R.M., Sasakawa, C., and Kaper, J.B. (2001) EspG, a novel type III system-secreted protein from Enteropathogenic Escherichia coli with similarities to VirA of Shigella flexneri. Infect Immun 69: 4027-4033.
21. Enocksson, A., Lundberg, J., Weitzberg, E., Norrby-Teglund, A., and Svenungsson, B. (2004) Rectal nitric oxide gas and stool cytokine levels during the course of infectious gastroenteritis. Clin Diagn Lab Immunol 11: 250-254.
22. Fang, F.C. (1997) Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest 99: 2818-2825.
23. Green, L.C., Wagner, D.A., Glogowshi, J., Skipper, P.L., Wishnok, J.S., and Tannenbaum, S.R. (1982) Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem 126: 131-138.
24. Hauf, N., and Chakraborty, T. (2003) Suppression of NF-kappa B activation and proinflammatory cytokine expression by Shiga toxin-producing Escherichia coli. J Immunol 170: 2074-2082.
25. Hayden, M.S., and Ghosh, S. (2004) Signaling to NF-kappaB. Genes Dev 18: 2195-2224.
26. Hecht, G. (1999) Innate mechanisms of epithelial host defense: spotlight on intestine. Am J Physiol 277: C351-C358.
27. Hecht, G., Marrero, J.A., Danilkovich, A., Matkowskyj, K.A., Savkovic, S.D., Koutsouris, A., and Benya, R.V. (1999) Pathogenic Escherichia coli increase CI- secretion from intestinal epithelia by upregulating galanin-1 receptor expression. J Clin Invest 104: 253-262.
28. Hicks, S., Frankel, G., Kaper, J.B., Dougan, G., and Phillips, A.D. (1998) Role of intimin and bundle-forming pili in enteropathogenic Escherichia coli adhesion to pediatric intestinal tissue in vitro. Infect Immun 66: 1570-1578.
29. Hill, S.M., Phillips, A.D., and Walker-Smith, J.A. (1991) Enteropathogenic Escherichia coli and life threatening chronic diarrhoea. Gut 32: 154-158.
30. Jarvis, K.G., Giron, J.A., Jerse, A.E., McDaniel, T.K., Donnenberg, M.S., and Kaper, J.B. (1995) Enteropathogenic Escherichia coli contains a putative type III secretion system necessary for the export of proteins involved in attaching and effacing lesion formation. Proc Natl Acad Sci USA 92: 7996-8000.
31. Jenkins, D.C., Charles, I.G., Baylis, S.A., Lelchuk, R., Radomski, M.W., and Moncada, S. (1994) Human colon cancer cell lines show a diverse pattern of nitric oxide synthase gene expression and nitric oxide generation. Br J Cancer 70: 847-849.
32. Jepson, M.A., Pellegrin, S., Peto, L., Banbury, D.N., Leard, A.D., Mellor, H., and Kenny, B. (2003) Synergistic roles for the Map and Tir effector molecules in mediating uptake of enteropathogenic Escherichia coli (EPEC) into non-phagocytic cells. Cell Microbiol 5: 773-783.
33. Kaper, J.B., McDaniel, T.K., Jarvis, K.G., and Gomez-Duarte, O. (1997) Genetics of virulence of enteropathogenic E. coli. Adv Exp Med Biol 412: 279-287.
34. Kaper, J.B., Nataro, J.P., and Mobley, H.L. (2004) Pathogenic Escherichia coli. Nat Rev Microbiol 2: 123-140.
35. Kenny, B., and Jepson, M. (2000) Targeting of an enteropathogenic Escherichia coli (EPEC) effector protein to host mitochondria. Cell Microbiol 2: 579-590.
36. Kenny, B., DeVinney, R., Stein, M., Reinscheid, D.J., Frey, E.A., and Finlay, B.B. (1997) Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell 91: 511-520.
37. Kenny, B., Ellis, S., Leard, A.D., Warawa, J., Mellor, H., and Jepson, M.A. (2002) Co-ordinate regulation of distinct host cell signalling pathways by multifunctional enteropathogenic Escherichia coli effector molecules. Mol Microbiol 44: 1095-1107.
38. Kim, J.M., Kim, J.S., Jung, H.C., Song, I.S., and Kim, C.Y. (2002) Up-regulation of inducible nitric oxide synthase and nitric oxide in Helicobacter pylori-infected human gastric epithelial cells: possible role of interferon-gamma in polarized nitric oxide secretion. Helicobacter 7: 116-128.
39. Kodama, T., Akeda, Y., Kono, G., Takahashi, A., Imura, K., Iida, T., and Honda, T. (2002) The EspB protein of enterohaemorrhagic Escherichia coli interacts directly with alpha-catenin. Cell Microbiol 4: 213-222.
40. Kolios, G., Brown, Z., Robson, R.L., Robertson, D.A., and Westwick, J. (1995) Inducible nitric oxide synthase activity and expression in a human colonic epithelial cell line, HT-29. Br J Pharmacol 116: 2866-2872.
41. Kolios, G., Valatas, V., and Ward, S.G. (2004) Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle. Immunology 113: 427-437.
42. Kunzelmann, K., and Mall, M. (2002) Electrolyte transport in the mammalian colon: mechanisms and implications for disease. Physiol Rev 82: 245-289.
43. Laemmli, U. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
44. Levine, M.M., Nataro, J.P., Karch, H., Baldini, M.M., Kaper, J.B., Black, R.E., et al. (1985) The diarrheal response of humans to some classic serotypes of enteropathogenic Escherichia coli is dependent on a plasmid encoding an enteroadhesiveness factor. J Infect Dis 152: 550-559.
45. Linn, S.C., Morelli, P.J., Edry, I., Cottongim, S.E., Szabo, C., and Salzman, A.L. (1997) Transcriptional regulation of human inducible nitric oxide synthase gene in an intestinal epithelial cell line. Am J Physiol 272: G1499-G1508.
46. Luperchio, S.A., and Schauer, D.B. (2001) Molecular pathogenesis of Citrobacter rodentium and transmissible murine colonic hyperplasia. Microbes Infect 3: 333-340.
47. McNamara, B.P., Koutsouris, A., O'Connell, C.B., Nougayrede, J.P., Donnenberg, M.S., and Hecht, G. (2001) Translocated EspF protein from enteropathogenic Escherichia coli disrupts host intestinal barrier function. J Clin Invest 107: 621-629.
48. Marches, O., Nougayrede, J.P., Boullier, S., Mainil, J., Charlier, G., Raymond, I., et al. (2000) Role of tir and intimin in the virulence of rabbit enteropathogenic Escherichia coli serotype O103:H2. Infect Immun 68: 2171-2182.
49. Marches, O., Ledger, T.N., Boury, M., Ohara, M., Tu, X., Goffaux, F., et al. (2003) Enteropathogenic and enterohaemorrhagic Escherichia coli deliver a novel effector called Cif, which blocks cell cycle G2/M transition. Mol Microbiol 50: 1553-1567.
50. Matsuzawa, T., Kuwae, A., Yoshida, S., Sasakawa, C., and Abe, A. (2004) Enteropathogenic Escherichia coli activates the RhoA signaling pathway via the stimulation of GEF-H1. EMBO J 23: 3570-3582.
51. Mellies, J.L., Navarro-Garcia, F., Okeke, I., Frederickson, J., Nataro, J.P., and Kaper, J.B. (2001) espC pathogenicity island of enteropathogenic Escherichia coli encodes an enterotoxin. Infect Immun 69: 315-324.
52. Nadler, E.P., Upperman, J.S., Dickinson, E.C., and Ford, H.R. (1999) Nitric oxide and intestinal barrier failure. Semin Pediatr Surg 8: 148-154.
53. Nagai, T., Abe, A., and Sasakawa, C. (2005) Targeting of enteropathogenic Escherichia coli EspF to host mitochondria is essential for bacterial pathogenesis: critical role of the 16th leucine residue in EspF. J Biol Chem 280: 2998-3011.
54. Nataro, J.P., and Kaper, J.B. (1998) Diarrheagenic Escherichia coli. Clin Microbiol Rev 11: 142-201.
55. Palmer, R.M., Ferrige, A.G., and Moncada, S. (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524-526.
56. Pinto, M., Robine-Leon, S., Appay, M.-D., Kedinger, M., Triadou, N., Dussaulx, E., et al. (1983) Enterocyte-like differentiation and polarisation of the humancolon carcinoma cell line Caco-2 in culture. Biol Cell 47: 323-330.
57. Salzman, A.L., Eaves-Pyles, T., Linn, S.C., Denenberg, A.G., and Szabo, C. (1998) Bacterial induction of inducible nitric oxide synthase in cultured human intestinal epithelial cells. Gastroenterology 114: 93-102.
58. Sappington, P.L., Han, X., Yang, R., Delude, R.L., and Fink, M.P. (2003) Ethyl pyruvate ameliorates intestinal epithelial barrier dysfunction in endotoxemic mice and immunostimulated caco-2 enterocytic monolayers. J Pharmacol Exp Ther 304: 464-476.
59. Saura, M., Zaragoza, C., Bao, C., McMillan, A., and Lowenstein, C.J. (1999) Interaction of interferon regulatory factor-1 and nuclear factor kappaB during activation of inducible nitric oxide synthase transcription. J Mol Biol 289: 459-471.
60. Savidge, T.C., Shmakov, A.N., Walker-Smith, J.A., and Phillips, A.D. (1996) Epithelial cell proliferation in childhood enteropathies. Gut 39: 185-193.
61. Savkovic, S.D., Koutsouris, A., and Hecht, G. (1997) Activation of NF-kappaB in intestinal epithelial cells by enteropathogenic Escherichia coli. Am J Physiol 273: C1160-C1167.
62. Savkovic, S.D., Ramaswamy, A., Koutsouris, A., and Hecht, G. (2001) EPEC-activated ERK1/2 participate in inflammatory response but not tight junction barrier disruption. Am J Physiol Gastrointest Liver Physiol 281: G890-G898.
63. Simmons, C.P., Goncalves, N.S., Ghaem-Maghami, M., Bajaj-Elliott, M., Clare, S., Neves, B., et al. (2002) Impaired resistance and enhanced pathology during infection with a noninvasive, attaching-effacing enteric bacterial pathogen, Citrobacter rodentium, in mice lacking IL-12 or IFN-gamma. J Immunol 168: 1804-1812.
64. Spitz, J., Yuhan, R., Koutsouris, A., Blatt, C., Alverdy, J., and Hecht, G. (1995) Enteropathogenic Escherichia coli adherence to intestinal epithelial monolayers diminishes barrier function. Am J Physiol 268: G374-G379.
65. Stein, M., Kenny, B., Stein, M.A., and Finlay, B.B. (1996) Characterization of EspC, a 110-kilodalton protein secreted by enteropathogenic Escherichia coli which is homologous to members of the immunoglobulin A protease-like family of secreted proteins. J Bacteriol 178: 6546-6554.
66. Tato, C.M., and Hunter, C.A. (2002) Host-pathogen interactions: subversion and utilization of the NF-kappa B pathway during infection. Infect Immun 70: 3311-3317.
67. Tu, X., Nisan, I., Yona, C., Hanski, E., and Rosenshine, I. (2003) EspH, a new cytoskeleton-modulating effector of enterohaemorrhagic and enteropathogenic Escherichia coli. Mol Microbiol 47: 595-606.
68. Vallance, B.A., Deng, W., De Grado, M., Chan, C., Jacobson, K., and Finlay, B.B. (2002a) Modulation of inducible nitric oxide synthase expression by the attaching and effacing bacterial pathogen Citrobacter rodentium in infected mice. Infect Immun 70: 6424-6435.
69. Vallance, B.A., Chan, C., Robertson, M.L., and Finlay, B.B. (2002b) Enteropathogenic and enterohemorrhagic Escherichia coli infections: emerging themes in pathogenesis and prevention. Can J Gastroenterol 16: 771-778.
70. Vignoli, A.L., Srivastava, R.C., Stammati, A., Turco, L., Tanori, M., and Zucco, F. (2001) Nitric oxide production in Caco-2 cells exposed to different inducers, inhibitors and natural toxins. Toxicol In Vitro 15: 289-295.
71. Warawa, J., Finlay, B.B., and Kenny, B. (1999) Type III secretion-dependent hemolytic activity of enteropathogenic Escherichia coli. Infect Immun 67: 5538-5540.
72. Witthoft, T., Eckmann, L., Kim, J.M., and Kagnoff, M.F. (1998) Enteroinvasive bacteria directly activate expression of iNOS and NO production in human colon epithelial cells. Am J Physiol 275: G564-G571.
73. Yamamoto, Y., and Gaynor, R.B. (2004) IkappaB kinases: key regulators of the NF-kappaB pathway. Trends Biochem Sci 29: 72-79.